| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-11 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |